Transient EDTA‐dependent pseudothrombocytopenia and ulcerative colitis recurrence during chemotherapy: A case of misleading platelet count results attributable to a laboratory artifact

KEY CLINICAL MESSAGE: EDTA‐dependent pseudothrombocytopenia as well as myelosuppression should be suspected when thrombocytopenia occurs in patients with autoimmune disease during chemotherapy. ABSTRACT: A patient with pancreatic cancer and ulcerative colitis developed transient ethylenediaminetetra...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Ayako, Toshima, Hirokazu, Saeki, Misa, Nagata, Takuya, Koyanagi, Tatsuo, Minamizawa, Masumi, Kashiwabara, Yuka, Kobayashi, Koji, Shimada, Ken, Momo, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663534/
https://www.ncbi.nlm.nih.gov/pubmed/38028043
http://dx.doi.org/10.1002/ccr3.8153
Descripción
Sumario:KEY CLINICAL MESSAGE: EDTA‐dependent pseudothrombocytopenia as well as myelosuppression should be suspected when thrombocytopenia occurs in patients with autoimmune disease during chemotherapy. ABSTRACT: A patient with pancreatic cancer and ulcerative colitis developed transient ethylenediaminetetraacetic acid (EDTA)‐dependent pseudothrombocytopenia with exacerbation of ulcerative colitis during chemotherapy. Unfortunately, pseudothrombocytopenia could not be immediately detected because thrombocytopenia was masked by a reasonable time course of adverse events associated with chemotherapy and ulcerative colitis recurrence. When thrombocytopenia occurs during chemotherapy, especially in patients with autoimmune diseases, EDTA‐dependent pseudothrombocytopenia and bone marrow suppression caused by anti‐cancer agents should be suspected.

Ejemplares similares